STAA News and Press, STAAR Surgical Company From 09/20/22

Summary STAAR Surgical continues to demonstrate the fundamental equity premia investors are seeking out in FY22. The buy thesis remains intact from previous analysis on STAA in our estimate and here I've gone over the company's latest numbers. I've made no changes to the $98 p...

Joe Jonas and STAAR Host Media Day in NYC EVO ICL Patient Education Expanded to Social Media and YouTube with Millions of Views STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems ...

If there's a single word that encapsulates what most investors want from their stocks, it's growth, growth, and even more growth. And even amid a market downturn, inflation, and issues with the global supply chain, the good news is that there are plenty of places to find monster growth, as ...

STAAR Surgical (NASDAQ: STAA) stock was up by 16% as of 3:36 p.m. ET on Thursday after it smashed the market's expectations for its second-quarter earnings, reporting net sales of $81.1 million and $0.26 in net income per diluted share. That works out to be 30% growth in its total r...

STAAR Surgical ( NASDAQ: STAA ) rises ~15% after the company posted better-than-expected Q2 result. The company's posted profit of $0.42 beats, which beat by $0.19, while Revenue rose 30% Y/Y to $81.1M, and beat by $0.98M. ICL Sales of $77.9M Up 32% Y/Y. Op...

Start Time: 16:30 End Time: 17:20 STAAR Surgical Company (STAA) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 PM ET Company Participants Caren Mason - President and CEO Patrick Williams - CFO Brian Moore - VP, Investor, Media Relations and Corpo...

Joe Jonas to Share his Experience with EVO in a Global Campaign that Highlights his Personal Journey to Achieve Visual Freedom STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the e...

ICL Units Up 42% Y/Y; Constant Currency Net Sales of $84.2 Million Announces Partnership with Joe Jonas to Raise EVO Global Awareness STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery sy...

Baillie Gifford’s 13F portfolio value decreased from ~$143B to ~$97.51B this quarter. They increased Spotify and Royalty Pharma while decreasing Cloudflare, Petrobras, BeiGene, CBRE Group, Teladoc, and Peloton Interactive. The top three positions are Moderna, Tesla Motors, ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 1, 2022 on Wednesday, August 10, 2...